Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Redox imbalance dictates dependence on GOT1 versus GOT2 for rod photoreceptor health during aging and stress.

Redox biology·2026

Same author

Redox imbalance dictates dependence on GOT1 versus GOT2 for rod photoreceptor health during aging and stress.

bioRxiv : the preprint server for biology·2026

Same author

Ultra High-Resolution Ultrasound Features of Carpal Tunnel Syndrome in Transthyretin Amyloidosis: A Cross-Sectional Study.

Muscle & nerve·2026

Same author

Operationalizing Next-Generation Sequencing in a Community-Based Academic Cancer Center: Workflow, Integration, and Impact.

Cancers·2026

Same author

Updates on Rhabdomyolysis: A Clinically Oriented Narrative Review.

Chest·2026

Same author

Don't Sweat the Swelling: Exercise Volume's Transient Effects in Trained Men.

International journal of sports medicine·2026

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

Recent progress in dengue vaccine research and development.

Nicholas Miller¹

¹Beremans Ltd, Cambridge, Cambridgeshire, UK. nm01@beremans.com

Current Opinion in Molecular Therapeutics

|February 9, 2010

Summary

Developing dengue vaccines focuses on eliciting immunity through specific viral components. Strategies aim to enhance neutralizing antibodies and cell-mediated responses while minimizing risks like antibody-dependent enhancement (ADE) for improved safety and efficacy.

Area of Science:

Virology
Immunology
Vaccinology

Background:

Dengue immunity can be achieved through humoral or cell-mediated responses.
Antibody-dependent enhancement (ADE) is a concern with non-neutralizing antibodies.
Current dengue vaccine development faces challenges in achieving broad efficacy and safety.

Purpose of the Study:

To review recent advancements in dengue vaccine development.
To explore strategies for inducing effective and safe immune responses against dengue virus.
To discuss the role of specific viral epitopes and protein components in vaccine design.

Main Methods:

Analysis of immune responses elicited by targeting specific dengue virus envelope protein (Env) domain III (DIII) epitopes.
Investigating the use of consensus Env DIII sequences to direct immune responses.

More Related Videos

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

Portable Paper-Based Immunoassay Combined with Smartphone Application for Colorimetric and Quantitative Detection of Dengue NS1 Antigen

Portable Paper-Based Immunoassay Combined with Smartphone Application for Colorimetric and Quantitative Detection of Dengue NS1 Antigen

Published on: January 26, 2024

Related Experiment Videos

Last Updated: Jun 16, 2026

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

Portable Paper-Based Immunoassay Combined with Smartphone Application for Colorimetric and Quantitative Detection of Dengue NS1 Antigen

Portable Paper-Based Immunoassay Combined with Smartphone Application for Colorimetric and Quantitative Detection of Dengue NS1 Antigen

Published on: January 26, 2024

Evaluating vaccines incorporating capsid and non-structural (NS) proteins for cell-mediated immunity.

Main Results:

Targeting serotype-specific DIII epitopes may induce neutralizing antibodies.
Removing cross-reactive epitopes and using consensus sequences may improve vaccine safety by reducing ADE.
Capsid and NS protein-based vaccines show potential for inducing cell-mediated immunity, but safety requires further investigation.

Conclusions:

Vaccine strategies focusing on DIII epitopes and consensus sequences show promise for safe and effective dengue vaccines.
Further research is needed to understand and mitigate the pathological potential of cell-mediated immunity induced by dengue vaccines.
Modifications to viral proteins, such as truncated NS1, may be crucial for optimizing vaccine safety.